Specialized Medical Company (TADAWUL:4019)
Saudi Arabia
· Delayed Price · Currency is SAR 18.95
+0.25 (1.34%)
At close: Dec 4, 2025
TADAWUL:4019 Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 158.4 | 185.22 | 168.7 | 102.96 | 55.97 | 46.02 |
| Depreciation & Amortization | 92.58 | 87.48 | 87.76 | 103.94 | 102.94 | 84.58 |
| Loss (Gain) From Sale of Assets | 2.49 | 2.29 | 0.02 | -0.06 | -0.05 | -0.11 |
| Provision & Write-off of Bad Debts | -0.22 | 9.68 | 6.21 | 36.13 | 51.32 | 4.56 |
| Other Operating Activities | 46.8 | 48.05 | 56.65 | 34.69 | 23.28 | 21.68 |
| Change in Accounts Receivable | 141.09 | 92.16 | -89.05 | -121.1 | -111.96 | -49.46 |
| Change in Inventory | -4.64 | 3.19 | -5.89 | -0.79 | 4.56 | 0.89 |
| Change in Accounts Payable | 0.78 | -10.99 | 4.68 | 14.87 | -32.13 | 43.63 |
| Change in Other Net Operating Assets | -18.53 | -33.3 | 4.3 | 6.85 | -178.17 | 48.28 |
| Operating Cash Flow | 418.75 | 383.78 | 233.37 | 177.48 | -84.25 | 200.07 |
| Operating Cash Flow Growth | 99.91% | 64.45% | 31.49% | - | - | - |
| Capital Expenditures | -89.29 | -94.27 | -72.84 | -60.89 | -75.14 | -202.75 |
| Sale of Property, Plant & Equipment | 0.91 | 0.93 | 0.84 | 0.06 | 0.2 | 0.13 |
| Investing Cash Flow | -88.38 | -93.34 | -72 | -60.82 | -74.94 | -202.62 |
| Short-Term Debt Issued | - | 75.54 | 20 | 15 | 170 | 80 |
| Long-Term Debt Issued | - | - | - | - | 47.71 | - |
| Total Debt Issued | 107.37 | 75.54 | 20 | 15 | 217.71 | 80 |
| Long-Term Debt Repaid | - | -85.51 | -53.44 | -46.96 | -25.84 | -48.81 |
| Net Debt Issued (Repaid) | -73.07 | -9.98 | -33.44 | -31.96 | 191.88 | 31.19 |
| Common Dividends Paid | -100 | -200 | -60 | -50 | -35 | -40 |
| Other Financing Activities | 66.83 | -35.81 | -41.88 | -25.73 | -16.34 | -11.21 |
| Financing Cash Flow | -106.24 | -245.78 | -135.33 | -107.69 | 140.54 | -20.02 |
| Net Cash Flow | 224.12 | 44.66 | 26.04 | 8.97 | -18.65 | -22.56 |
| Free Cash Flow | 329.45 | 289.52 | 160.53 | 116.6 | -159.38 | -2.68 |
| Free Cash Flow Growth | 211.12% | 80.35% | 37.68% | - | - | - |
| Free Cash Flow Margin | 22.56% | 20.11% | 11.73% | 9.65% | -15.13% | -0.31% |
| Free Cash Flow Per Share | 1.32 | 1.16 | 1.89 | 1.37 | -18.75 | -0.32 |
| Cash Interest Paid | 33.17 | 35.81 | 41.88 | 25.73 | 16.34 | 11.21 |
| Levered Free Cash Flow | 218.73 | 172.76 | 41.2 | 251.67 | -201.45 | - |
| Unlevered Free Cash Flow | 245.63 | 200.87 | 71.48 | 270.31 | -189.65 | - |
| Change in Working Capital | 118.7 | 51.06 | -85.97 | -100.17 | -317.69 | 43.34 |
Source: S&P Capital IQ. Standard template. Financial Sources.